Previous studies have demonstrated the development of a hypercoagulable state in colon cancer patients with elevated markers of coagulation, including thrombin-antithrombin complex, prothrombin fragment 1 + 2, soluble fibrin, and total fibrin(ogen) degradation products fibrinogen [5, 6]. The gene discussed is F2; the disease is colonic neoplasm.